Whitinsville woman faces up to 20 years in prison for adderall distribution
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Sobrescribir enlaces de ayuda a la navegación

  • Inicio
  • Whitinsville woman faces up to 20 years in prison for adderall distribution

Whitinsville woman faces up to 20 years in prison for adderall distribution

Febrero 14, 2019
|
Share Article
|
Download Press Release
For Immediate Release
Contact: Kristen Govostes
Phone Number: (617) 557-2100

BOSTON – A Whitinsville woman pleaded guilty today in federal court in Worcester to her role in a conspiracy to distribute the amphetamine Adderall.

 

Meghan Giacomuzzi, 36, pleaded guilty to one count of conspiracy to distribute and to possess with intent to distribute Adderall and six counts of distributing and dispensing Adderall. U.S. District Court Judge Timothy S. Hillman scheduled sentencing for May 14, 2019. Giacomuzzi was charged by Information in November 2018.

 

Between October 2016 and February 2018, Giacomuzzi conspired with others to distribute Adderall, an amphetamine, for uses other than a legitimate medical purpose and not in the usual course of medical practice. While working for Leslie Caraceni, M.D., at her medical practice in Whitinsville, Giacomuzzi wrote prescriptions for controlled substances, including Adderall, for patients who had not been examined or diagnosed by Caraceni, using prescription pads provided by Caraceni, and then sold the prescriptions to patients. Giacomuzzi would then deliver cash payments to Caraceni at her residence or leave cash in the medical office for Caraceni to collect, while payments made by debit or credit card were paid to a bank account controlled by Caraceni.

 

Caraceni was charged in November 2018 and has pleaded not guilty and is awaiting trial.

 

The charge of conspiracy to distribute, dispense, and possess with intent to distribute Adderall carries a sentence of up to 20 years in prison, at least three years of supervised release, and a fine of up to $1 million. The charge of distributing, dispensing, and possessing with the intent of distributing Adderall also carries a sentence of up to 20 years in prison, at least three years of supervised release, and a fine of up to $1 million. Sentences are imposed by a federal district court judge based upon the U.S. Sentencing Guidelines and other statutory factors.

 

Brian D. Boyle Special Agent in Charge of the DEA’s New England Division and United States Attorney Andrew E. Lelling made the announcement today.

Download Press Release
###
Amphetamines
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Stephen Belleau, Acting Special Agent in Charge - New England
@DEANewEngland
  • Facebook
  • X
  • Email

SAMHSA Behavioral Health Treatment Locator

  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster

United States Drug Enforcement Administration

Back
  • Quiénes somos
  • Recursos
Back
  • Sobre la DEA
  • Mission
  • Nuestra historia
  • Divisiones Nacionales
  • DEA Museum
  • Wall of Honor
  • Contáctenos
Back
  • Operational Divisions
Back
  • Submit a Tip
  • Extortion Scam
  • Public Affairs
  • Social Media Directory
Back
  • Illegal Online Pharmacies
  • OD Justice
  • Fentanyl Supply Chain
  • Pill Press Resources
  • Recovery Resources
  • Together for Families
  • Ley de Libertad de Información
  • Publications
  • Galerías Multimedia
  • Programa de Asistencia a Testigos para Víctimas
Back
  • Fee Waiver
Back
  • Human Trafficking Prevention
  • Submit A Tip +
  • Get Updates
  • Scam Alert
    • English
    • Español